It’s crucial to investigate the reasons why data science teams require context, consistency, and secure collaboration of their data to ensure data science success. Let's quickly examine each of these requirements so that we can better understand what data science success moving forward may look like.
Vancouver, British Columbia – TheNewswire – January 10, 2022 – Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTC:LEXTF) is pleased to announce the signing of a Memorandum of Understanding (the “MOU”) between its wholly owned subsidiary Egret Bioscience Ltd. (“Egret”) and Panacea Plant Sciences Inc. (“Panacea”), a leading United States biotechnology company focused on developing new therapeutic, cultivation, extraction and isolation techniques for high […]
DUBLIN–(BUSINESS WIRE)–The “Disposable Pipette Tips Market Forecast to 2028 – COVID-19 Impact and Global Analysis” report has been added to ResearchAndMarkets.com’s offering. The disposable pipette tips market is projected to reach US$ 166.57 million by 2028 from US$ 88.51 million in 2021; it is expected to grow at a CAGR of 9.5% from 2021 to […]
DUBLIN–(BUSINESS WIRE)–The “Virtual Data Rooms Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029” report has been added to ResearchAndMarkets.com’s offering. The global virtual data rooms market is expected to grow at a CAGR of 15% during the forecast period (2021-2029). Need to Effectively Manage […]
QuantiFERON franchise benefits from new applications, products and automation options, building on strengths in tuberculosis detection while addressing new disease targets QuantiFERON SARS-CoV-2 assay launched in December 2021 now CE-marked for clinical use measuring SARS-CoV-2 T-cell responses QuantiFERON-TB Gold Plus assay for TB detection set to benefit from three additional U.S. patient groups: Individuals with […]
The biopharmaceutical market is growing faster than ever, with two production systems competing for market dominance: mammalian cells and microorganisms. In recent years, based on the rise of antibody-based therapies, new biotherapeutic approvals have favored mammalian hosts. However, not only has extensive research elevated our understanding of microbes to new levels, but emerging therapeutic molecules also facilitate their use; thus, is it time for microbes to fight back? In this review, we answer this timely question by cross-comparing four microbial production hosts and examining the innovations made to both their secretion and post-translational modification (PTM) capabilities.